Since its discovery in 1962, Ketamine has been used as a potent dissociative anesthetic and analgesic stimulant. The FDA approved Ketalar in 1970, and because of its dosage strength and fast-acting mirror molecular structure, it is used at IV-infusion clinics like Lone Star Infusion to treat anxiety and depression, which has led to the rise of Ketamine usage in the middle class.
Factors Boosting Ketamine Usage
Ketamine’s popularity among the Middle class has risen because of its effectiveness for mind-altering amnestic, sedative, mood, and painkilling benefits. Ketamine IV infusion therapy is considered the most popular form of treatment today for pain and mood disorders. A generic formula for Ketamine is widely used to treat depression, so physicians promote it professionally. It is also supported medically because its treatment value has many advantageous benefits.
For a high number of Middle-Class patients, Ketamine is administered medicinally at infusion therapy clinics to treat conditions like depression and anxiety. Ketamine also has a party drug reputation because of Special K, which party-goers often use as an anesthetic. Esketamine, a Ketamine by-product, is also gaining more traction in 2019 for neurological and psychological disorders because it is FDA approved, but Ketamine infusion remains the preferred treatment.
The new product is not as powerful, and patients are finding it less effective. The FDA also set stricter requirements for patient accessibility, including it must be in the form of a nasal spray and taken with one other antidepressant prescription. Patients must also have already used two previous antidepressants before being prescribed Esketamine. It is only available in certified Ketamine clinics as well. It is because of these strict uses that IV infusion is still more popular.
Ketamine IV infusion therapy is clinically considered the most formidable treatment for anxiety, depression, PTSD, psychological stress, chronic pain, and mood and pain disorders. Ketamine is also widely available, which speaks to why many patients are opting for Ketamine over its newer counterpart. There is also some evidence to suggest that Esketamine is less effective than Ketamine infusion therapy since its formula is made from only the left molecular structure.
Middle-class patients are also weighing effectiveness. Studies of Ketamine usage support IV infusion therapy as the most effective treatment for depressive disorders over the nasal spray formula. Seven-out-of-ten patients report positive results with IV treatments over 4.5-out-of-ten nasal spray users. Physicians also caution Ketamine clinicians that nasal spray should be considered a secondary form of therapy when their patients are unable to take IV treatments.
These findings also support why more Middle-Class patients are opting for IV infusion therapy to receive the Ketamine over the Esketamine product. There is also some discussion by this group of users of costs associated with Ketamine and Esketamine. Ketamine clinics charge about $1350 for four doses while Esketamine providers charge as much as $7000 for similar doses. For most Middle-class income earners, the high cost for Esketamine far outweighs the benefits.
Ketamine is the preferred treatment by clinicians because of its safety profile. There is also a therapeutic range of administrative techniques, although most patients favor IV infusion therapy.